PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21998327-3	2011	Pharmacological inhibition of PKCalpha/beta with Ro-32-0432, Ro-31-8220 or ruboxistaurin (LY333531) similarly enhances cardiac function and antagonizes heart failure in multiple models of disease in both mice and rats.	Ro 32-0432	49-59	protein kinase C, alpha	Mus musculus	30-38	
24863469-10	2014	Blocking of PKC signaling with Ro-32-0432, an inhibitor specific for PKC-alpha and -beta at nanomolar concentration, produced a dramatic reduction of ipsilateral axons from both nasal retina and temporal crescent.	Ro 32-0432	31-41	protein kinase C, alpha	Mus musculus	69-78	
24553404-9	2014	pretreatment with the protein kinase Calpha (PKCalpha) inhibitor Ro-32-0432 completely restored the reduced morphine antinociception in the contralateral paw but only partially restored it in the ipsilateral paw in the inflammatory pain state.	Ro 32-0432	65-75	protein kinase C, alpha	Mus musculus	22-43	
24553404-9	2014	pretreatment with the protein kinase Calpha (PKCalpha) inhibitor Ro-32-0432 completely restored the reduced morphine antinociception in the contralateral paw but only partially restored it in the ipsilateral paw in the inflammatory pain state.	Ro 32-0432	65-75	protein kinase C, alpha	Mus musculus	45-53	
11108799-5	2000	The observations that a selective activator of protein kinase C (PKC)-alpha (sapintoxin D) mimics the PMA effect, whereas a selective PKC-alpha inhibitor (Ro-320432) antagonizes this effect, suggest a regulatory role of PKC-alpha in the LPS signaling pathway in mouse BMC.	Ro 32-0432	155-164	protein kinase C, alpha	Mus musculus	134-143	
11356858-5	2001	Concomitant intrathecal administration of a specific PKC inhibitor Ro-32-0432 with DAMGO blocked the attenuation of DAMGO-induced G-protein activation that was caused by chronic DAMGO treatment.	Ro 32-0432	67-77	protein kinase C, alpha	Mus musculus	53-56	
34505505-6	2021	Interestingly, the PKCalpha-selective blocker Ro-32-0432 could compete with EGCG for the same substrate-binding pocket of PKCalpha.	Ro 32-0432	46-56	protein kinase C, alpha	Mus musculus	19-27	
34505505-6	2021	Interestingly, the PKCalpha-selective blocker Ro-32-0432 could compete with EGCG for the same substrate-binding pocket of PKCalpha.	Ro 32-0432	46-56	protein kinase C, alpha	Mus musculus	122-130